Divis lab share nse
WebDivis Laboratories Ltd (DIVISLAB) share price is ₹2803.10 and its price to earning (PE) is 30.90. A high PE ratio indicates that a share price is overvalued, or investors are … Web2 days ago · The 30-share BSE Sensex climbed 125 points or 0.21 per cent to trade at 60,283, while the broader NSE Nifty moved 51 points or 0.29 per cent higher to trade at 17,773. ... Divi's Lab was the top ...
Divis lab share nse
Did you know?
WebDec 30, 2024 · Divi's Laboratories Ltd., incorporated in the year 1990, is a Large Cap company (having a market cap of Rs 122688.96 Crore) operating in Pharmaceuticals sector. ... Divi's Laboratories share price stocks to buy markets market news sensex nifty investment DIVIS LABS ... stock market news Sbi stock price NSE Stock Paytm Share … WebApr 12, 2024 · Stay updated on the latest Divis Laboratories Ltd share on NSE/BSE price with real-time data, charts, and analysis. View historical Divis Laboratories Ltd stock …
WebApr 3, 2024 · F&O Quote of Divis Lab Share Price, Future and Options Divis Lab Live BSE, NSE Charts, historical charts, F&O Quote, Stock quote of Divis Lab, Divis Lab … WebDivi's Laboratories Option Chain - Latest updates on Live Nifty/NSE 50 Option Chain, Nifty Stock Options prices,Bank Nifty Option Chain, Charts & more on Groww.in. Divi's Labs. Option Chain. Expiry. OI (lots) CALL PRICE STRIKE PRICE PUT PRICE. OI (lots)-- …
WebDivis Laboratories had last split the face value of its shares from Rs 10 to Rs 2 in 2007. The share has been quoting on an ex-split basis from August 03, 2007. Splits History (Divis Laboratories) WebDivis Laboratories share price today, Live quotes, charts, analysis, intraday movements, highs and lows on BSE and NSE. Track DIVISLAB stock performance daily, weekly, …
WebYour technical analysis summary for DIVI'S LABORATORIE. This gauge displays a real-time technical analysis overview for your selected timeframe. The summary of DIVI'S LABORATORIE is based on the most popular technical indicators, such as Moving Averages, Oscillators and Pivots. Learn more .
WebNov 8, 2024 · Jefferies has downgraded its rating on shares of Divi's Laboratories to 'hold' following the Q2 revenue and EBITDA miss as compared to its estimates. Pfizer's COVID oral drug candidate Paxlovid shows the efficacy of 89 percent, which could pose a threat to Divi's Laboratories' Molnupiravir prospects. Jefferies said the stock is trading at an ... grade 12 mathematics november 2020 paper 1WebApr 12, 2024 · BOM : 532488 NSE : DIVISLAB : LT : Long Term Analysis ... SHARE PRICE MOMENTUM OF DIVIS LABORATORIES . ... Is DIVIS LABORATORIES trading at a Premium or Discount? As on Apr 12,2024, DIVIS LABORATORIES is trading at a Premium of 26% based on the estimates of Median Intrinsic Value! chilly weather gifWebApr 11, 2024 · While Divi's Laboratories Limited (NSE:DIVISLAB) shareholders are probably generally happy, the stock hasn't had particularly good run recently, with the … chilly water bottles amazonWebMar 19, 2024 · View 27 reports from 9 analysts offering long term price targets for Divi's Laboratories Ltd.. Divi's Laboratories Ltd. has an average target of 3221.62. The consensus estimate represents an upside of 14.11% from the last price of 2823.35. Reco - This broker has downgraded this stock from it's previous report. grade 12 mathematics june past papersWebFeb 11, 2024 · Divi's Labs Plunges 14%, Hits 52-Wk Low on Glum Q3, EBITDA Margin Nosedives. By Malvika Gurung Investing.com -- Shares of the pharmaceutical major Divi's Laboratories (NS:DIVI) plunged 14.44% on Friday and hit a new 52-week low of Rs 2,795 apiece during the intraday... Investing.com. Feb 03, 2024 11:17. grade 12 mathematics mobile application appWeb2 days ago · Dr Reddy’s Laboratories. Shares of Dr Reddy’s Laboratories ended among top gainers on Nifty50 on Wednesday. The stock rose nearly 2.22 per cent to Rs 4,869 per share on the NSE. Axis Securities has recommended buying shares of Dr Reddy’s Laboratories for a target price of Rs 5,100 which is an upside of 4.2 per cent. grade 12 mathematics mobile app for pcWebNov 9, 2024 · EBITDA margins declined 767 bps YoY to 33.5 per cent due to high energy and transport costs. Shares of Divi’s Laboratories hit a 52-week low of Rs 3,344.60, down 2 per cent on the BSE in Wednesday’s intra-day trade. In past two days, the stock of pharmaceuticals company has cracked 11 per cen. chilly weather even on the set